image
Evelo Biosciences, Inc. EVLO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.00045
0 %
$ 8.54 K
Market Cap
0.0
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2022-12-31 0.00% 6.26% 6.01%
Annual Report FY 10-K 2021-12-31 0.00% -30.44% -25.59%
Annual Report FY 10-K 2020-12-31 0.00% -9.34% -6.40%
Annual Report FY 10-K 2019-12-31 0.00% -59.06% -48.63%
Annual Report FY 10-K 2018-12-31 0.00% -92.01% -111.05%
Annual Report FY 10-K 2017-12-31 0.00% -110.37% -111.37%
Annual Report FY 10-K 2016-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2023-09-30 0.00% 59.55% 61.51%
Quarterly Report Q2 8-K 2023-06-30 0.00% 30.95% 33.84%
Quarterly Report Q1 8-K 2023-03-31 0.00% 15.14% 13.36%
Quarterly Report Q4 8-K 2022-12-31 0.00% 17.84% 23.48%
Quarterly Report Q3 8-K 2022-09-30 0.00% 9.39% 11.18%
Quarterly Report Q2 8-K 2022-06-30 0.00% 3.28% -6.98%
Quarterly Report Q1 8-K 2022-03-31 0.00% -5.91% -4.61%
Quarterly Report Q4 8-K 2021-12-31 0.00% 1.37% 2.27%
Quarterly Report Q3 8-K 2021-09-30 0.00% -61.21% -62.08%
Quarterly Report Q2 8-K 2021-06-30 0.00% -53.00% -36.61%
Quarterly Report Q1 8-K 2021-03-31 0.00% -22.37% -18.10%
Quarterly Report Q4 8-K 2020-12-31 0.00% -28.55% -24.38%
Quarterly Report Q3 8-K 2020-09-30 0.00% 3.28% 6.11%
Quarterly Report Q2 8-K 2020-06-30 0.00% 1.38% 5.34%
Quarterly Report Q1 8-K 2020-03-31 0.00% -13.51% -11.81%
Quarterly Report Q4 8-K 2019-12-31 0.00% -46.34% -41.75%
Quarterly Report Q3 8-K 2019-09-30 0.00% -36.43% -30.62%
Quarterly Report Q2 8-K 2019-06-30 0.00% -38.26% -40.45%
Quarterly Report Q1 8-K 2019-03-31 0.00% -93.32% -99.56%
Quarterly Report Q4 8-K 2018-12-31 0.00% -89.65% -98.25%
Quarterly Report Q3 8-K 2018-09-30 0.00% -94.02% -104.74%
Quarterly Report Q2 8-K 2018-06-30 0.00% -138.11% -144.90%
Quarterly Report Q1 8-K 2018-03-31 0.00% -95.53% -100.17%
Quarterly Report Q4 8-K 2017-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2017-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2017-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2017-03-31 0.00% 0.00% 0.00%